Personalized network-based treatments in oncology
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Personalized network-based treatments in oncology. / Robin, X; Creixell, P; Radetskaya, O; Santini, C C; Longden, J; Linding, Rune.
In: Clinical Pharmacology and Therapeutics, Vol. 94, No. 6, 12.2013, p. 646-650.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Personalized network-based treatments in oncology
AU - Robin, X
AU - Creixell, P
AU - Radetskaya, O
AU - Santini, C C
AU - Longden, J
AU - Linding, Rune
PY - 2013/12
Y1 - 2013/12
N2 - Network medicine aims at unraveling cell signaling networks to propose personalized treatments for patients suffering from complex diseases. In this short review, we show the relevance of network medicine to cancer treatment by outlining the potential convergence points of the most recent technological and scientific developments in both drug design and signaling network analysis.
AB - Network medicine aims at unraveling cell signaling networks to propose personalized treatments for patients suffering from complex diseases. In this short review, we show the relevance of network medicine to cancer treatment by outlining the potential convergence points of the most recent technological and scientific developments in both drug design and signaling network analysis.
KW - Animals
KW - Antineoplastic Combined Chemotherapy Protocols
KW - Biological Markers
KW - Drug Design
KW - Humans
KW - Individualized Medicine
KW - Molecular Targeted Therapy
KW - Neoplasms
KW - Protein Interaction Maps
KW - Protein Processing, Post-Translational
KW - Signal Transduction
KW - Systems Biology
U2 - 10.1038/clpt.2013.171
DO - 10.1038/clpt.2013.171
M3 - Journal article
C2 - 23995267
VL - 94
SP - 646
EP - 650
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 6
ER -
ID: 122676190